Loading...
10 Asia Endocrinology Drugs Reports
Region Covered: Asia
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: AbbVie Inc, AstraZeneca Plc, Novartis AG, Novo Nordisk A/S, Eli Lilly and Company
Region Covered: Asia
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Abbvie Inc., Merck KGaA, Pfizer Inc., Exelixis Inc., Viatris Inc.
Region Covered: Asia
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Lannett Company, Inc, Horizon Therapeutics plc, Takeda Pharmaceutical Company Ltd, GlaxoSmithKline Plc, Regeneron Pharmaceuticals, Inc.
Region Covered: Asia
Study Period: 2021 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Sanzyme, Merck & Co. Inc., Ferring BV, Fresenius Kabi AG, Sun Pharmaceutical Industries Ltd
Region Covered: Asia
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Endo International Plc, AbbVie Inc, Pfizer Inc, Teva Pharmaceutical Industries Ltd, Allergan Plc
Region Covered: Asia
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Pfizer, Inc, Novartis AG, Astrazeneca Plc, Merck & Co., Inc, Sun Pharma
Region Covered: Asia
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Pfizer Inc, Ipsen, Chiasma, Inc, Validus Pharmaceuticals LLC, Novartis AG
Region Covered: Asia
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Abbott Laboratories Inc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd, Endo International, Ferring Pharmaceuticals
Region Covered: Asia
Study Period: 2019 - 2029
Major Players: Takeda Pharmaceutical Company Limited, Merck KGaA, Sandoz International GmbH, Pfizer Inc., Bristol-Myers Squibb Company
Region Covered: Asia
Study Period: 2019 - 2029
Major Players: Horizon Therapeutics plc, Pfizer Inc., Novartis AG, Johnson & Johnson Services, Inc. (Johnson & Johnson Vision Care, Inc.), AbbVie Inc.
Filter Reports
By Countries
